Korean J Gastroenterol.  2021 Apr;77(4):160-163. 10.4166/kjg.2021.403.

How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease

  • 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea


Patients with inflammatory bowel disease (IBD) are generally considered to be more vulnerable to coronavirus disease 2019 (COVID-19). In addition, there are many concerns about the risk of severe COVID-19 infection in patients with IBD. Because the uncertainty of COVID-19 can cause confusions for patients with chronic diseases, physicians should be able to provide adequate advice for optimal treatment for patients with IBD. As the COVID-19 pandemic continues, current knowledge of COVID-19 is changing based on numerous empirical guidance and clinical data being updated daily. Based on the latest evidence, we will discuss the appropriate strategy and management of patients with IBD in the era of COVID-19.


COVID-19; Pandemics; Inflammatory bowel diseases
Full Text Links
  • KJG
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr